Literature DB >> 31333115

Sarcopenia in Ovarian Cancer Patients, Oncologic Outcomes Revealing the Importance of Clinical Nutrition: Review of Literature.

Stefano Cianci1, Valerio Rumolo1, Andrea Rosati1, Giuseppe Scaletta1, Salvatore Gueli Alletti1, Taís Marques Cerentini2, Zaki Sleiman3, Patricia Lordelo4, Daniela Angerame5, Giorgia Garganese1, Stefano Uccella6, Mattia Tarascio1, Giovanni Scambia1.   

Abstract

INTRODUCTION: Ovarian cancer is the leading cause of death among gynecological malignancies. Its usual clinical manifestation is at advanced stages, with nutritional impairment, weight loss, and a consequent decline in skeletal muscle mass and strength (defined as sarcopenia). The relationship between sarcopenia and decreased survival was demonstrated not only in ovarian cancer but also in other cancer types, such as hepatocellular, pancreatic, lung, colon, cervical, metastatic breast, and renal cancer. The aim of this study is to review the current evidence regarding the relationship between sarcopenia and the surgical and oncological outcomes in ovarian cancer patients.
METHODS: The systematic search was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRSIMA) statement. The terms "SARCOPENIA" AND "OVARIAN CANCER" were systematically used to search PubMed and Scopus databases. Original reports in English language were identified, with the purpose to include all relevant papers regarding the role of sarcopenia and indicators of skeletal muscle quality assessment in gynecological ovarian cancer.
RESULTS: A total of 9 studies were considered eligible for the present review. The strength of recommendation was moderate and the level of evidence was low in all selected articles. No prospective studies were conducted and most of the papers were case-control series comparing ovarian cancer sarcopenic population vs. non sarcopenic population.
CONCLUSIONS: Sarcopenia appears to have an important role in oncological outcomes of ovarian cancer patients. However, sarcopenia occurrence during disease history and mechanisms underlying the possible impairment in prognosis should be better investigated. Prospective trials are awaited in order to obtain a better insight in this topic. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Ovarian cancer; body mass index; gynecological malignancies; nutrition; nutritional impairment; sarcopenia.

Mesh:

Year:  2019        PMID: 31333115     DOI: 10.2174/1381612825666190722112808

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  11 in total

Review 1.  Laparotomy vs. minimally invasive surgery for ovarian cancer recurrence: a systematic review.

Authors:  Stefano Uccella; Massimo P Franchi; Stefano Cianci; Pier Carlo Zorzato; Francesca Bertoli; Salvatore Gueli Alletti; Fabio Ghezzi; Giovanni Scambia
Journal:  Gland Surg       Date:  2020-08

Review 2.  Pre-treatment sarcopenic assessments as a prognostic factor for gynaecology cancer outcomes: systematic review and meta-analysis.

Authors:  E H Sutton; M Plyta; K Fragkos; S Di Caro
Journal:  Eur J Clin Nutr       Date:  2022-02-22       Impact factor: 4.016

Review 3.  Surgery vs. chemotherapy for ovarian cancer recurrence: what is the best treatment option.

Authors:  Vito Andrea Capozzi; Andrea Rosati; Luigi Carlo Turco; Giulio Sozzi; Matteo Riccò; Benito Chiofalo; Giuseppe Vizzielli
Journal:  Gland Surg       Date:  2020-08

Review 4.  Secondary and tertiary ovarian cancer recurrence: what is the best management?

Authors:  Simone Garzon; Antonio Simone Laganà; Jvan Casarin; Ricciarda Raffaelli; Antonella Cromi; Massimo Franchi; Fabio Barra; Ibrahim Alkatout; Simone Ferrero; Fabio Ghezzi
Journal:  Gland Surg       Date:  2020-08

Review 5.  Development of new medical treatment for epithelial ovarian cancer recurrence.

Authors:  Rosanna Mancari; Giuseppe Cutillo; Valentina Bruno; Cristina Vincenzoni; Emanuela Mancini; Ermelinda Baiocco; Simone Bruni; Giuseppe Vocaturo; Benito Chiofalo; Enrico Vizza
Journal:  Gland Surg       Date:  2020-08

Review 6.  Role of ultrasound in the detection of recurrent ovarian cancer: a review of the literature.

Authors:  Andrea Rosati; Salvatore Gueli Alletti; Vito Andrea Capozzi; Mariateresa Mirandola; Virginia Vargiu; Camilla Fedele; Stefano Uccella; Carmine Vascone
Journal:  Gland Surg       Date:  2020-08

7.  Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery: A Large Single-Center Experience.

Authors:  Barbara Costantini; Virginia Vargiu; Francesco Santullo; Andrea Rosati; Matteo Bruno; Valerio Gallotta; Claudio Lodoli; Rossana Moroni; Fabio Pacelli; Giovanni Scambia; Anna Fagotti
Journal:  Ann Surg Oncol       Date:  2022-04-18       Impact factor: 4.339

8.  Low intensity pulsed ultrasound information technology intervention in diagnosis and prediction of Muscle Atrophy.

Authors:  Zhijun Sun
Journal:  Pak J Med Sci       Date:  2021       Impact factor: 1.088

9.  Sentinel Lymph Node in Aged Endometrial Cancer Patients "The SAGE Study": A Multicenter Experience.

Authors:  Stefano Cianci; Andrea Rosati; Virginia Vargiu; Vito Andrea Capozzi; Giulio Sozzi; Alessandro Gioè; Salvatore Gueli Alletti; Alfredo Ercoli; Francesco Cosentino; Roberto Berretta; Vito Chiantera; Giovanni Scambia; Francesco Fanfani
Journal:  Front Oncol       Date:  2021-10-19       Impact factor: 6.244

10.  Total Parenteral Nutrition Treatment Improves the Nutrition Status of Gynecological Cancer Patients by Improving Serum Albumin Level.

Authors:  Xin Yan; Sanyuan Zhang; Junmei Jia; Jiaolin Yang; Yilai Song; Haoran Duan
Journal:  Front Med (Lausanne)       Date:  2022-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.